Library

Protocol

KLOW (80 mg Vial)

Complete dosage protocol and reconstitution guide for KLOW (80 mg Vial).

Updated November 25, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismKLOW is a four-peptide blend (GHK-Cu, BPC-157, KPV, TB-500) formulated for advanced tissue repair and inflammation reduction. Components individually promote wound healing: thymosin β4 (TB-500) and BPC-157 accelerate angiogenesis and tissue regeneration in models [1] [2] , and GHK-Cu stimulates collagen production and skin remodeling [3] .
Dosing2,700–5,300 mcg (~ 2.7–5.3 mg ) once daily (gradual titration).
ReconstitutionAdd 3.0 mL diluent to a 80 mg vial.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.

Calculator preset

Run the vial math before tracking.

At ~26.67 mg/mL, 10 units ~ 2,667 mcg , 15 units ~ 4,000 mcg and 20 units ~ 5,333 mcg on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

KLOW is a four-peptide blend (GHK-Cu, BPC-157, KPV, TB-500) formulated for advanced tissue repair and inflammation reduction. Components individually promote wound healing: thymosin β4 (TB-500) and BPC-157 accelerate angiogenesis and tissue regeneration in models [1] [2] , and GHK-Cu stimulates collagen production and skin remodeling [3] . This educational protocol outlines a once-daily subcutaneous regimen using a practical 3.0 mL dilution for precise dosing.

ReconstituteAdd 3.0 mL bacteriostatic water (max vial capacity) → ~ 26.7 mg/mL total peptide concentration.
Reference dose2,700–5,300 mcg (~ 2.7–5.3 mg ) once daily (gradual titration).
Easy measuringAt ~26.67 mg/mL, 10 units ~ 2,667 mcg , 15 units ~ 4,000 mcg and 20 units ~ 5,333 mcg on a U-100 syringe.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~26.7 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–22,667 mcg10 units (0.10 mL)
Weeks 3–64,000 mcg15 units (0.15 mL)
Weeks 7–125,333 mcg20 units (0.20 mL)

2,700–5,300 mcg (~ 2.7–5.3 mg ) once daily (gradual titration).

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the inside wall of the vial to minimize frothing.
  3. Gently swirl or roll to dissolve (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protecting from light.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide Vials 8 weeks ≈ 4 vials
  • 12 weeks ≈ 6 vials
  • 16 weeks ≈ 8 vials
Insulin Syringes Per week: 7 syringes (1/day)
  • 8 weeks: 56 syringes
  • 12 weeks: 84 syringes
  • 16 weeks: 112 syringes
Bacteriostatic Water Use ~3.0 mL per vial for reconstitution.
  • 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
  • 12 weeks (6 vials): 18 mL → 2 × 10 mL bottles
  • 16 weeks (8 vials): 24 mL → 3 × 10 mL bottles
Alcohol Swabs One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
  • 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
  • 16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Protocol Overview

  • Goal: Support tissue repair and reduce inflammation to promote healing [1] .
  • Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
  • Dose Range: ~2.7–5.3 mg total peptide daily with gradual titration.
  • Reconstitution: 3.0 mL per vial (~26.7 mg/mL) for accurate dosing.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

  • Suggested daily titration approach.
  • Start: 10 units (~2.7 mg total) daily; increase by ~5 units (~1.3 mg) every 2–4 weeks.
  • Target: 15–20 units (~4–5.3 mg) daily by Weeks 3–6.
  • Frequency: Once per day (subcutaneous) [7] .
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks.
  • Timing: Consistent schedule; rotate injection sites.

Storage Instructions

  • Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • Practical considerations for consistency and safety.
  • Use a new sterile insulin syringe for each injection; dispose in a sharps container [8] .
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
  • Inject slowly; hold the needle in place a few seconds before withdrawing.
  • Record daily dose and site rotation to maintain consistency.

05 · How it works

How This Works

KLOW is a four-peptide blend (GHK-Cu, BPC-157, KPV, TB-500) formulated for advanced tissue repair and inflammation reduction.

Components individually promote wound healing: thymosin β4 (TB-500) and BPC-157 accelerate angiogenesis and tissue regeneration in models [1] [2] , and GHK-Cu stimulates collagen production and skin remodeling [3] .

This educational protocol outlines a once-daily subcutaneous regimen using a practical 3.0 mL dilution for precise dosing.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • KLOW observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.

Related pages

Keep researching